Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal.Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel, 15%,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now